These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 17257744)

  • 1. CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers.
    Huang B; Lei Z; Zhao J; Gong W; Liu J; Chen Z; Liu Y; Li D; Yuan Y; Zhang GM; Feng ZH
    Cancer Lett; 2007 Jul; 252(1):86-92. PubMed ID: 17257744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR2 expression by brain microvascular endothelial cells is critical for macrophage transendothelial migration in response to CCL2.
    Dzenko KA; Song L; Ge S; Kuziel WA; Pachter JS
    Microvasc Res; 2005 Jul; 70(1-2):53-64. PubMed ID: 15927208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL2-independent role of CCR2 in immune responses against Leishmania major.
    Quinones MP; Estrada CA; Jimenez F; Martinez H; Willmon O; Kuziel WA; Ahuja SK; Ahuja SS
    Parasite Immunol; 2007 Apr; 29(4):211-7. PubMed ID: 17371458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2.
    Ringe J; Strassburg S; Neumann K; Endres M; Notter M; Burmester GR; Kaps C; Sittinger M
    J Cell Biochem; 2007 May; 101(1):135-46. PubMed ID: 17295203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocrine CCL2 promotes cell migration and invasion via PKC activation and tyrosine phosphorylation of paxillin in bladder cancer cells.
    Chiu HY; Sun KH; Chen SY; Wang HH; Lee MY; Tsou YC; Jwo SC; Sun GH; Tang SJ
    Cytokine; 2012 Aug; 59(2):423-32. PubMed ID: 22617682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective role of the inflammatory CCR2/CCL2 chemokine pathway through recruitment of type 1 cytotoxic γδ T lymphocytes to tumor beds.
    Lança T; Costa MF; Gonçalves-Sousa N; Rei M; Grosso AR; Penido C; Silva-Santos B
    J Immunol; 2013 Jun; 190(12):6673-80. PubMed ID: 23686489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of CCL2-CCR2A/2B signaling for monocyte migration into spheroids of breast cancer-derived fibroblasts.
    Ksiazkiewicz M; Gottfried E; Kreutz M; Mack M; Hofstaedter F; Kunz-Schughart LA
    Immunobiology; 2010; 215(9-10):737-47. PubMed ID: 20605053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury.
    Dimitrijevic OB; Stamatovic SM; Keep RF; Andjelkovic AV
    J Cereb Blood Flow Metab; 2006 Jun; 26(6):797-810. PubMed ID: 16192992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of CC chemokines in gammadelta T lymphocyte trafficking during allergic inflammation: the role of CCL2/CCR2 pathway.
    Penido C; Costa MF; Souza MC; Costa KA; Candéa AL; Benjamim CF; Henriques Md
    Int Immunol; 2008 Jan; 20(1):129-39. PubMed ID: 18056919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive neuronal expression of CCR2 chemokine receptor and its colocalization with neurotransmitters in normal rat brain: functional effect of MCP-1/CCL2 on calcium mobilization in primary cultured neurons.
    Banisadr G; Gosselin RD; Mechighel P; Rostène W; Kitabgi P; Mélik Parsadaniantz S
    J Comp Neurol; 2005 Nov; 492(2):178-92. PubMed ID: 16196033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An engineered GM-CSF-CCL2 fusokine is a potent inhibitor of CCR2-driven inflammation as demonstrated in a murine model of inflammatory arthritis.
    Rafei M; Berchiche YA; Birman E; Boivin MN; Young YK; Wu JH; Heveker N; Galipeau J
    J Immunol; 2009 Aug; 183(3):1759-66. PubMed ID: 19592643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the CCL2/CCR2 Axis in Cancer Immunotherapy: One Stone, Three Birds?
    Fei L; Ren X; Yu H; Zhan Y
    Front Immunol; 2021; 12():771210. PubMed ID: 34804061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel activator of C-C chemokine, FROUNT, is expressed with C-C chemokine receptor 2 and its ligand in failing human heart.
    Satoh M; Akatsu T; Ishkawa Y; Minami Y; Nakamura M
    J Card Fail; 2007 Mar; 13(2):114-9. PubMed ID: 17395051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid NEMO deficiency promotes tumor immunosuppression partly via MCP1-CCR2 axis.
    Yuanyuan L; Yakun L; Zhongyao L; Le Y; Weisong D; Moran G; Hui B; Chunyan L
    Exp Cell Res; 2021 Feb; 399(2):112467. PubMed ID: 33428904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model.
    Teng KY; Han J; Zhang X; Hsu SH; He S; Wani NA; Barajas JM; Snyder LA; Frankel WL; Caligiuri MA; Jacob ST; Yu J; Ghoshal K
    Mol Cancer Ther; 2017 Feb; 16(2):312-322. PubMed ID: 27980102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking mast cell-mediated type I hypersensitivity in experimental allergic conjunctivitis by monocyte chemoattractant protein-1/CCR2.
    Tominaga T; Miyazaki D; Sasaki S; Mihara S; Komatsu N; Yakura K; Inoue Y
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5181-8. PubMed ID: 19553621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel recombinant fusion protein encoding a 20-amino acid residue of the third extracellular (E3) domain of CCR2 neutralizes the biological activity of CCL2.
    Izhak L; Wildbaum G; Zohar Y; Anunu R; Klapper L; Elkeles A; Seagal J; Yefenof E; Ayalon-Soffer M; Karin N
    J Immunol; 2009 Jul; 183(1):732-9. PubMed ID: 19535619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCL2 (Monocyte Chemoattractant Protein-1) in cancer bone metastases.
    Craig MJ; Loberg RD
    Cancer Metastasis Rev; 2006 Dec; 25(4):611-9. PubMed ID: 17160712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-conditioned Gr-1(+)CD11b(+) myeloid cells induce angiogenesis through the synergistic action of CCL2 and CXCL16 in vitro.
    Han EC; Lee J; Ryu SW; Choi C
    Biochem Biophys Res Commun; 2014 Jan; 443(4):1218-25. PubMed ID: 24388986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human periosteum-derived progenitor cells express distinct chemokine receptors and migrate upon stimulation with CCL2, CCL25, CXCL8, CXCL12, and CXCL13.
    Stich S; Loch A; Leinhase I; Neumann K; Kaps C; Sittinger M; Ringe J
    Eur J Cell Biol; 2008 Jun; 87(6):365-76. PubMed ID: 18501472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.